We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Philips Unveils Rembra CT Scanner to Speed Up Medical Imaging
Read MoreHide Full Article
Key Takeaways
Philips launches the Rembra CT system, capable of 106 images per second and up to 270 patient scans daily.
Philips' scanner has an 85-cm bore and advanced imaging to help doctors view small anatomical details clearly.
PHG stock rose 7.6% in a year; it expects 2026 comps growth of 3-4.5% and $1.3-$1.5B free cash flow.
Koninklijke Philips (PHG - Free Report) shares have risen 7.6% in a year, outperforming the Zacks Medical sector's decline of 0.3%. The outperformance is driven by strong demand and higher order intake, coupled with solid growth across businesses and regions, and strong performance in the personal health segment.
In addition, the company’s expanding portfolio is expected to boost prospects. On March 5, Philips unveiled its next-generation radiology CT system called Rembra at the European Congress of Radiology 2026 in Vienna. The new system is designed to provide suitable help to hospitals to handle high patient volumes in emergency and high-demand imaging environments.
Rembra uses advanced image-reconstruction technology, which has the capacity to produce up to 106 images per second, allowing doctors to view scan results instantly. The system can also support as many as 270 patient scans per day, assisting hospitals in managing busy radiology departments. The CT scanner includes a large 85-centimeter bore, providing additional space for patients and making it easier to scan people with complex medical conditions, trauma injuries or obesity. The technology assists doctors in clearly viewing small anatomical details and improving diagnostic confidence.
Apart from hospital equipment, Philips sells consumer health and personal care products, which include Philips OneBlade shavers, Philips Sonicare DiamondClean electric toothbrushes and beauty and grooming devices. These products assist the company in generating high sales volumes and strong margins.
The Zacks Consensus Estimate for first-quarter 2026 net sales is pegged at $4.6 billion, indicating a year-over-year increase of 6.77%. The consensus mark for the first-quarter earnings is pegged at 24 cents per share, unchanged over the past seven days, indicating a year-over-year decline of 11.1%.
Philips now expects comparable sales growth to be between 3% and 4.5%, adjusted EBITDA margin to be between 12.5% and 13% and free cash flow to be between EUR 1.3 billion and 1.5 billion for 2026.
The Zacks Consensus Estimate for 2026 net sales is pegged at $22 billion, indicating a year-over-year increase of 8.9%. The consensus mark for the 2026 earnings is pegged at $1.87 per share, up by 24 cents over the past 30 days, indicating a year-over-year jump of 6.3%.
PHG’s Zacks Rank & Other Stocks to Consider
Philips currently flaunts a Zacks Rank #1 (Strong Buy).
Long-term earnings growth rates for Brookdale Senior Living, BrightSpring Health Services and Catalyst Pharmaceuticals are currently pegged at 34.1%, 47.2% and 12.5%, respectively. Shares of Brookdale Senior Living, BrightSpring Health Services and Catalyst Pharmaceuticals have appreciated 156.2%, 138.9% and 10.7%, respectively, over the past 12 months.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Philips Unveils Rembra CT Scanner to Speed Up Medical Imaging
Key Takeaways
Koninklijke Philips (PHG - Free Report) shares have risen 7.6% in a year, outperforming the Zacks Medical sector's decline of 0.3%. The outperformance is driven by strong demand and higher order intake, coupled with solid growth across businesses and regions, and strong performance in the personal health segment.
In addition, the company’s expanding portfolio is expected to boost prospects. On March 5, Philips unveiled its next-generation radiology CT system called Rembra at the European Congress of Radiology 2026 in Vienna. The new system is designed to provide suitable help to hospitals to handle high patient volumes in emergency and high-demand imaging environments.
Rembra uses advanced image-reconstruction technology, which has the capacity to produce up to 106 images per second, allowing doctors to view scan results instantly. The system can also support as many as 270 patient scans per day, assisting hospitals in managing busy radiology departments. The CT scanner includes a large 85-centimeter bore, providing additional space for patients and making it easier to scan people with complex medical conditions, trauma injuries or obesity. The technology assists doctors in clearly viewing small anatomical details and improving diagnostic confidence.
Apart from hospital equipment, Philips sells consumer health and personal care products, which include Philips OneBlade shavers, Philips Sonicare DiamondClean electric toothbrushes and beauty and grooming devices. These products assist the company in generating high sales volumes and strong margins.
Koninklijke Philips N.V. Price and Consensus
Koninklijke Philips N.V. price-consensus-chart | Koninklijke Philips N.V. Quote
Philips Provides Upbeat 2026 Outlook
The Zacks Consensus Estimate for first-quarter 2026 net sales is pegged at $4.6 billion, indicating a year-over-year increase of 6.77%. The consensus mark for the first-quarter earnings is pegged at 24 cents per share, unchanged over the past seven days, indicating a year-over-year decline of 11.1%.
Philips now expects comparable sales growth to be between 3% and 4.5%, adjusted EBITDA margin to be between 12.5% and 13% and free cash flow to be between EUR 1.3 billion and 1.5 billion for 2026.
The Zacks Consensus Estimate for 2026 net sales is pegged at $22 billion, indicating a year-over-year increase of 8.9%. The consensus mark for the 2026 earnings is pegged at $1.87 per share, up by 24 cents over the past 30 days, indicating a year-over-year jump of 6.3%.
PHG’s Zacks Rank & Other Stocks to Consider
Philips currently flaunts a Zacks Rank #1 (Strong Buy).
Some other top-ranked stocks in the broader Zacks Medical sector are Brookdale Senior Living (BKD - Free Report) , BrightSpring Health Services (BTSG - Free Report) and Catalyst Pharmaceuticals (CPRX - Free Report) , each sporting a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rates for Brookdale Senior Living, BrightSpring Health Services and Catalyst Pharmaceuticals are currently pegged at 34.1%, 47.2% and 12.5%, respectively. Shares of Brookdale Senior Living, BrightSpring Health Services and Catalyst Pharmaceuticals have appreciated 156.2%, 138.9% and 10.7%, respectively, over the past 12 months.